首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Serious arterial thromboembolic events (sATE) in patients (PTS) with metastatic colorectal cancer (MCRC) treated with bevacizumab (BV): Results from the BRiTE registry
被引:0
|
作者
:
Sugrue, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Sugrue, M.
Yi, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Yi, J.
Purdie, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Purdie, D.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Dong, W.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Grothey, A.
Kozoff, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Kozoff, M.
机构
:
[1]
Genentech Inc, San Francisco, CA 94080 USA
[2]
Mayo Clin, Rochester, MN USA
[3]
Ingalls Hosp, Harvey, IL USA
[4]
Univ Chicago, Harvey, IL USA
来源
:
ANNALS OF ONCOLOGY
|
2007年
/ 18卷
关键词
:
D O I
:
暂无
中图分类号
:
R73 [肿瘤学];
学科分类号
:
100214 ;
摘要
:
引用
收藏
页码:VII30 / VII30
页数:1
相关论文
共 50 条
[1]
Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizumab (BV): Results from the BRiTE registry
Sugrue, M. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Sugrue, M. M.
Yi, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Yi, J.
Purdie, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Purdie, D.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Dong, W.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Grothey, A.
Kozloff, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Kozloff, M.
JOURNAL OF CLINICAL ONCOLOGY,
2007,
25
(18)
[2]
Serious arterial thromboembolic events (sATE) in patients (pts) with metastatic colorectal cancer (mCRC) treated with bevacizurnab (BV): results from the BRITE registry
Sing, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA USA
Genentech Inc, San Francisco, CA USA
Sing, A.
Sugrue, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA USA
Genentech Inc, San Francisco, CA USA
Sugrue, M.
Chiruvolu, R.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA USA
Genentech Inc, San Francisco, CA USA
Chiruvolu, R.
Yi, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA USA
Genentech Inc, San Francisco, CA USA
Yi, J.
Purdie, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA USA
Genentech Inc, San Francisco, CA USA
Purdie, D.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA USA
Genentech Inc, San Francisco, CA USA
Dong, W.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin, Rochester, MN USA
Genentech Inc, San Francisco, CA USA
Grothey, A.
Kozloff, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Chicago, Ingalls Hosp, Harvey, KS USA
Genentech Inc, San Francisco, CA USA
Kozloff, M.
EJC SUPPLEMENTS,
2007,
5
(04):
: 249
-
249
[3]
Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients (pts) with metastatic colorectal cancer (mCRC): Results from the BRiTE observational cohort study
Kozloff, M. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Kozloff, M. F.
Sugrue, M. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Sugrue, M. M.
Purdie, D. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Purdie, D. M.
Berlin, J. D.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Berlin, J. D.
Flynn, P. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Flynn, P. J.
Kabbinavar, F. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Kabbinavar, F. F.
Sargent, D. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Sargent, D. J.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Dong, W.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Grothey, A.
JOURNAL OF CLINICAL ONCOLOGY,
2008,
26
(15)
[4]
Serious wound healing complications (sWHC) following surgery in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV): Results from the BRiTE observational cohort study (OCS)
Sugrue, M. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Sugrue, M. M.
Purdie, D. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Purdie, D. M.
Feng, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Feng, S.
Flynn, P. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Flynn, P. J.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Grothey, A.
Sargent, D. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Sargent, D. J.
Berlin, J. D.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Berlin, J. D.
Kabbinavar, F. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Kabbinavar, F. F.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Dong, W.
Kozloff, M. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hoboken, NJ USA
Kozloff, M. F.
JOURNAL OF CLINICAL ONCOLOGY,
2008,
26
(15)
[5]
ADVERSE EVENTS (AES) ASSOCIATED WITH BEVACIZUMAB (BV) IN OLDER PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC)
Shankaran, V.
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Shankaran, V.
Mummy, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Mummy, D.
Koepl, L.
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Koepl, L.
Blough, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Washington, Seattle, WA 98195 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Blough, D.
Yim, Y. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hlth Econ & Outcomes Res, San Francisco, CA 94080 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Yim, Y. M.
Yu, E.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, Hlth Econ & Outcomes Res, San Francisco, CA 94080 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Yu, E.
Ramsey, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
Ramsey, S.
ANNALS OF ONCOLOGY,
2012,
23
: 203
-
203
[6]
Incidence of serious bleeding events (sBE) in patients (pts) with metastatic colorectal cancer (mCRC) receiving bevacizumab (BV) as part of a first-line regimen: Results from the BRiTE observational cohort study (OCS)
Flynn, P. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Flynn, P. J.
Sugrue, M. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Sugrue, M. M.
Feng, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Feng, S.
Purdie, D. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Purdie, D. M.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Grothey, A.
Sargent, D. J.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Sargent, D. J.
Berlin, J. D.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Berlin, J. D.
Kabbinavar, F. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Kabbinavar, F. F.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Dong, W.
Kozloff, M. F.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Oncol Hematol PA, Minneapolis, MN USA
Kozloff, M. F.
JOURNAL OF CLINICAL ONCOLOGY,
2008,
26
(15)
[7]
Clinical outcomes in bevacizumab (BV)-treated patients (pts) with metastatic colorectal cancer (mCRC): Results from ARIES observational cohort study (OCS) and confirmation of BRITE data on BV beyond progression (BBP)
Cohn, A. L.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Cohn, A. L.
Bekaii-Saab, T.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Bekaii-Saab, T.
Bendell, J. C.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Bendell, J. C.
Hurwitz, H.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Hurwitz, H.
Kozloff, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Kozloff, M.
Roach, N.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Roach, N.
Tezcan, H.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Tezcan, H.
Feng, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Feng, S.
Sing, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Sing, A.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Rocky Mt Canc Ctr, Denver, CO USA
Grothey, A.
JOURNAL OF CLINICAL ONCOLOGY,
2010,
28
(15)
[8]
Treatment center (TC) variability in survival of patients (pts) with colorectal cancer (mCRC) treated with bevacizumab (BV): A subanalysis from the BRiTE Observational Study (OCS)
Barron, H. V.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Genentech Inc, San Francisco, CA 94080 USA
Barron, H. V.
Purdie, D. M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Genentech Inc, San Francisco, CA 94080 USA
Purdie, D. M.
Feng, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Genentech Inc, San Francisco, CA 94080 USA
Feng, S.
Sing, A. P.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Genentech Inc, San Francisco, CA 94080 USA
Sing, A. P.
JOURNAL OF CLINICAL ONCOLOGY,
2009,
27
(15)
[9]
Safety and effectiveness of bevacizumab (BV) and chemotherapy (CT) in elderly patients with metastatic colorectal cancer (MCRC): Results from the BRiTE observational cohort study
Kozloff, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Chicago, IL USA
Ingalls Hosp, Chicago, IL USA
Kozloff, M.
Sugrue, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Ingalls Hosp, Chicago, IL USA
Sugrue, M.
Chiruvolu, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Ingalls Hosp, Chicago, IL USA
Chiruvolu, P.
Purdie, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Ingalls Hosp, Chicago, IL USA
Purdie, D.
Berlin, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Vanderbilt Ingram Canc Ctr, Nashville, TN USA
Ingalls Hosp, Chicago, IL USA
Berlin, J.
Flynn, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Minnesota Onc Hem PA, Minneapolis, MN USA
Ingalls Hosp, Chicago, IL USA
Flynn, P.
Kabbinavar, F.
论文数:
0
引用数:
0
h-index:
0
机构:
Univ Calif Los Angeles, Los Angeles, CA USA
Ingalls Hosp, Chicago, IL USA
Kabbinavar, F.
Sargent, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin, Rochester, MN USA
Ingalls Hosp, Chicago, IL USA
Sargent, D.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Genentech Inc, San Francisco, CA 94080 USA
Ingalls Hosp, Chicago, IL USA
Dong, W.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Mayo Clin, Rochester, MN USA
Ingalls Hosp, Chicago, IL USA
Grothey, A.
ANNALS OF ONCOLOGY,
2008,
19
: 26
-
26
[10]
Management of hypertension (HTN) in patients (pts) with metastatic colorectal cancer (MCRC) treated with bevacizumab (BV) plus chemotherapy (CT)
Kozloff, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Kozloff, M.
Hainsworth, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Hainsworth, J.
Badarinath, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Badarinath, S.
Cohn, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Cohn, A.
Flynn, P.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Flynn, P.
Dong, W.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Dong, W.
Suzuki, S.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Suzuki, S.
Purdie, D.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Purdie, D.
Yi, J.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Yi, J.
Sugrue, M.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Sugrue, M.
Grothey, A.
论文数:
0
引用数:
0
h-index:
0
机构:
Ingalls Hosp, Harvey, IL USA
Grothey, A.
ANNALS OF ONCOLOGY,
2007,
18
: VII80
-
VII80
←
1
2
3
4
5
→